Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161


The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

Gray SW, Hornik RC, Schwartz JS, Armstrong K.

Clin Genet. 2012 Jan;81(1):29-37. doi: 10.1111/j.1399-0004.2011.01797.x. Epub 2011 Nov 2.


Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Gray SW, O'Grady C, Karp L, Smith D, Schwartz JS, Hornik RC, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1303-11. doi: 10.1158/1055-9965.EPI-08-0825. Epub 2009 Mar 24.


Reproductive decision-making in young female carriers of a BRCA mutation.

Donnelly LS, Watson M, Moynihan C, Bancroft E, Evans DG, Eeles R, Lavery S, Ormondroyd E.

Hum Reprod. 2013 Apr;28(4):1006-12. doi: 10.1093/humrep/des441. Epub 2013 Jan 4.


BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.

Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH.

Health Expect. 2008 Sep;11(3):220-31. doi: 10.1111/j.1369-7625.2008.00494.x.


Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.

Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, Jensen RA, Fabian CJ, Godwin AK.

Breast Cancer Res Treat. 2014 Jun;145(3):707-14. doi: 10.1007/s10549-014-2980-0. Epub 2014 May 7.


Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.

Vanstone M, Chow W, Lester L, Ainsworth P, Nisker J, Brackstone M.

Can Fam Physician. 2012 May;58(5):e258-66.


Attitudes toward direct-to-consumer advertisements and online genetic testing among high-risk women participating in a hereditary cancer clinic.

Perez GK, Cruess DG, Cruess S, Brewer M, Stroop J, Schwartz R, Greenstein R.

J Health Commun. 2011 Jul;16(6):607-28. doi: 10.1080/10810730.2011.551993. Epub 2011 May 24.


Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.

Ormondroyd E, Donnelly L, Moynihan C, Savona C, Bancroft E, Evans DG, Eeles R, Lavery S, Watson M.

Eur J Hum Genet. 2012 Jan;20(1):4-10. doi: 10.1038/ejhg.2011.146. Epub 2011 Aug 3.


Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.

Meaney-Delman D, Bellcross CA.

Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30. Review.


Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.

Bluman LG, Rimer BK, Regan Sterba K, Lancaster J, Clark S, Borstelmann N, Iglehart JD, Winer EP.

Psychooncology. 2003 Jul-Aug;12(5):410-27.


Primary care providers' willingness to recommend BRCA1/2 testing to adolescents.

O'Neill SC, Peshkin BN, Luta G, Abraham A, Walker LR, Tercyak KP.

Fam Cancer. 2010 Mar;9(1):43-50. doi: 10.1007/s10689-009-9243-y. Epub 2009 Apr 24.


An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.

Ratnayake P, Wakefield CE, Meiser B, Suthers G, Price MA, Duffy J; Kathleen Cuningham National Consortium for Research into Familial Breast Cancer, Tucker K.

Fam Cancer. 2011 Mar;10(1):97-105. doi: 10.1007/s10689-010-9383-0.


Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.

Metcalfe KA, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod SA.

Br J Cancer. 2009 Jan 27;100(2):421-5. doi: 10.1038/sj.bjc.6604830. Epub 2008 Dec 16.


Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City.

Sussner KM, Jandorf L, Thompson HS, Valdimarsdottir HB.

Psychooncology. 2013 Jul;22(7):1594-604. doi: 10.1002/pon.3187. Epub 2012 Sep 16.


Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.

Cancer. 2006 Dec 15;107(12):2745-51.


Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial.

Halbert CH, Kessler L, Troxel AB, Stopfer JE, Domchek S.

Public Health Genomics. 2010;13(7-8):440-8. doi: 10.1159/000293990. Epub 2010 Mar 17.


Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.

Woodson AH, Muse KI, Lin H, Jackson M, Mattair DN, Schover L, Woodard T, McKenzie L, Theriault RL, Hortobágyi GN, Arun B, Peterson SK, Profato J, Litton JK.

Oncologist. 2014 Aug;19(8):797-804. doi: 10.1634/theoncologist.2014-0057. Epub 2014 Jun 20.


Efficacy of a web-based intelligent tutoring system for communicating genetic risk of breast cancer: a fuzzy-trace theory approach.

Wolfe CR, Reyna VF, Widmer CL, Cedillos EM, Fisher CR, Brust-Renck PG, Weil AM.

Med Decis Making. 2015 Jan;35(1):46-59. doi: 10.1177/0272989X14535983. Epub 2014 May 14.


Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.


Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.

Greenup R, Buchanan A, Lorizio W, Rhoads K, Chan S, Leedom T, King R, McLennan J, Crawford B, Kelly Marcom P, Shelley Hwang E.

Ann Surg Oncol. 2013 Oct;20(10):3254-8. doi: 10.1245/s10434-013-3205-1. Epub 2013 Aug 22.

Items per page

Supplemental Content

Write to the Help Desk